Related Experiment Videos
Polypeptide resurfacing method improves fibroblast's adhesion to hyaluronan strands.
1Department of Functional Restoration, Stanford University, Palo Alto, California 94305, USA.
Journal of Biomedical Materials Research
|July 10, 1999
Summary
This study improved hyaluronic acid (hyaluronan) biomaterials for tissue engineering by using polypeptides to enhance cell adhesion. The modified hyaluronan shows promise for improved clinical applications due to better biocompatibility and cell attachment.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Cell Biology
Background:
- Hyaluronic acid (hyaluronan, HyA) is a natural matrix component crucial for cell adhesion and growth.
- HyA's high water solubility limits its application in artificial tissue matrices.
- Polypeptides can reduce HyA solubility and enhance cellular attachment through specific receptors.
Purpose of the Study:
- To develop a polypeptide resurfacing method to improve cell attachment to hyaluronic acid strands for tissue engineering.
- To evaluate the efficacy of modified HyA in promoting fibroblast adhesion and proliferation in vitro and in vivo.
Main Methods:
- Crosslinking of HyA strands using glutaraldehyde.
- Resurfacing of crosslinked HyA with various polypeptides (poly-D-lysine, poly-L-lysine, glycine, glutamine).
- In vitro evaluation of cell adhesion and proliferation using histological and immunohistochemical staining.
- In vivo implantation of modified HyA with fibroblast cells.
Main Results:
- Polylysine-modified HyA significantly enhanced fibroblast cell adhesion compared to unmodified HyA.
- Glutaraldehyde crosslinking effectively stabilized HyA strands, conferring resistance to biodegradation.
- Modified HyA demonstrated good biocompatibility in both in vitro and in vivo assessments.
Conclusions:
- Polypeptide resurfacing is an effective strategy to enhance cellular adhesion to hyaluronic acid-based biomaterials.
- Modified HyA exhibits improved properties for tissue engineering applications.
- Resurfaced HyA holds significant potential as an advanced biomaterial for clinical use.